Achrol, R. S.: 1991, ‘Evolution of the Marketing Organization: New Forms for Turbulent Environments,’ Journal of Marketing
Amerson, K.: 2007, ‘Direct-to-Consumer Pharmaceutical Advertising in Men’s and Women’s Magazines,’ Dissertation of Master of Arts, Texas Tech University.
Balsa, A. I., N. Seiler, T. G. McGuire, and G. Bloche: 2003, ‘Clinical Uncertainty and Healthcare Disparities,’ American Journal of Law and Medicine
Beauchamp, T. L. and J. F. Childress: 1994, Principles of Biomedical Ethics 4
ed. (Oxford University Press, Oxford).
Bloche, M. Gregg: 2007, ‘Consumer-Directed Health Care and the Disadvantaged,’ Health Affairs
Block, L. G. and P. A Keller: 1995, ‘When to Accentuate the Negative: The Effects of Perceived Efficacy and Message Framing on Intentions to Perform a Health-Related Behavior,’ Journal of Marketing Research
, 32 (May), 192-203.CrossRef
Blumenthal, D.: 2006, ‘Employer-Sponsored Insurance-Riding the Health Care Tiger,’ New England Journal of Medicine
, 355(2), 195-203.CrossRef
Buntin, M. B., C. Damberg, A. Haviland, K. Kapur, N. Lurie, R. McDevitt, and M. S. Marquis: 2006, ‘Consumer-Directed Health Care: Early Evidence about Effects on Cost and Quality,’ Health Affairs
, w516–w530 (published online 24 October 2006; 10.1377/hlthaff.25.w516
Caves, R. E., M. D. Whinston and M. A. Hurwitz: 1991, ‘Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry’, Brooking Papers, pp. 1–66.
Chamberlin, E.: 1933, The Theory of Monopolistic Competition (Harvard University Press, Cambridge).
Chandler, A. D.: 1990, Scale and Scope: The Dynamics of Industrial Capitalism (Belknap Press, Cambridge).
Charkham, J.: 1995, Keeping Good Company: A Study of Corporate Governance in Five Countries (Oxford University Press, Oxford).
Cockburn, I.M., and R.M. Henderson: 2001, ‘Scale and Scope in Drug Development: Unpacking the Advantages of Size in Pharmaceutical Research’’ Journal of Health Economics
Cohen, W.M., and D.A. Levinthal: 1989, ‘Innovation and Learning: The Two Faces of R&D,’ Economic Journal
Cowan, C.A., and M. B. Hartman: 2005, ‘Financing Health Care: Businesses, Households, and Governments, 1987-2003,’ Baltimore: Centers for Medicare & Medicaid Services, July.
Cumbler, E., H. Wald, and J. Kutner: 2009, ‘Lack of Patient Knowledge Regarding Hospital Medications,’ Journal of Hospital Medicine 5:83-86.
Daniels, N. and J. E. Sabin: 2002, Setting Limits Fairly: Can We Learn to Share Medical Resources? (Oxford University Press, Oxford).
Darling, H.: 2003, ‘Containing Costs: Corporate Employers’ Perspective.’ Health Affairs: Web Exclusives 2002, w91-93.
Davis, K. 2004: ‘Consumer- Directed Health Care: Will It Improve Health System Performance?’ Health Services Research
4, Part 2), 1219-1234.CrossRef
Day, G. S.: 1990, Market Driven Strategy (The Free Press, New York).
DeNavas-Walt, C., B. D. Proctor and C. H. Lee.: 2007, ‘Income, Poverty, and Health Insurance Coverage in the United States: 2005’, Current Population Reports: Consumer Income, August 2006, http://www.census.gov/prod/2006pubs/p60-231.pdf
. Accessed 13 April 2007.
Dickson, P.: 1996, ‘The Static and Dynamic Mechanics of Competition: A Comment on Hunt and Morgan’s Comparative Advantage Theory,’ Journal of Marketing
Dongre,Y., B. Mahadevappa, and R. Rohini : 2010, ‘Building Access to Healthcare in Rural India: Possibility and Feasibility of Low-Cost Medicine’, International Journal of Pharmaceutical and Healthcare Marketing,
Gagnon, M. A. and J. Lexchin: 2008, ‘The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditure in the United States’, PLoS Med
Galbraith, J. K.: 1992, The Culture of Contentment (Houghton Mifflin Company, New York).
Galvin, R. S. and S. Delbanco: 2005. ‘Why Employers Need to Rethink How They Buy Health Care’, Health Affairs
Galvin, R.S. and A. Milstein: 2002. ‘Large Employers’ New Strategies in Health Care’, New England Journal of Medicine
Gannes, S.: 1987, ‘The Riches in Market Niches,’ Fortune (April 27), 227–230.
Gleckman, H.: 2006, ‘A New Twist on Retiree Health Care’, Business Week, July 31, p. 68.
Gold M. R., J. E. Siegel, L. B. Russell, and M. C. Weinstein: 1996, Cost-Effectiveness in Health and Medicine, (Oxford Press, New York).
Goldstein, S. Z.: 2008, `How to Pay for Health Care', Washington Times, February 4, p. A19
Goyder, G.: 1993, The Just Enterprise: A Blueprint for the Responsible Company (Adamantine Press, London).
Grabowski, H. and J. Vernon: 1992, ‘Brand Loyalty Entry and Price Competition in Pharmaceuticals after the 1984 Drug Act,’ Journal of Law and Economics
Hall, M.: 1997, Making Medical Spending Decisions: The Law, Ethics, and Economics of Rationing Mechanisms. (Oxford University Press, Oxford).
Henderson, B. D.: 1983, ‘The Anatomy of Competition’, Journal of Marketing
Henderson, R. and I. Cockburn: 1996, `Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery', RAND Journal of Economics
Herzlinger, R. E.: 2002, ‘Let’s Put Consumers in Charge of Health Care’, Harvard Business Review
80 (7), 44-55.
Hunt, S. D. and R. M. Morgan: 1995, ‘The Comparative Advantage Theory of Competition,’ Journal of Marketing
Jacobs, M.: 1991, The Green Economy (Pluto, London).
Jacoby, J., D. E. Speller, and C. A. Kohn: 1974, ‘Brand Choice Behavior as a Function of Information Load’, Journal of Marketing Research
Jones, T. O. and W. E. Sasser: 1995, ‘Why Satisfied Customer Defects?’ Harvard
Kay, J.: 1995, Foundations of Corporate Success: How Business Strategies Add Value (Oxford University Press, Oxford).
Kohli, A. K. and B. J. Jaworski: 1990, ‘Market Orientation: The Construct, Research Propositions, and Managerial Implications’, Journal of Marketing
Kohn, A.: 1986, No Contest: The Case against Competition (Houghton Mifflin Company, Boston).
Lagnada, L. and E. Tanouye.: 2001, ‘Are Outrageous Prices Inhibiting Consumer Access to Life-Sustaining Drugs? Yes (Lucette Lagnado) No (Elsye Tanouye)’, in Barton, M. and Abhijit, R. (Eds), Taking Sides: Issues in Marketing, McGraw-Hill, New York, NY, 128-145.
Levin-Scherz, J.: 2010, ‘What Drives High Health Costs and How to Fight Back’, Harvard Business Review, April, 72–73.
Lexchin, J.: 2004, ‘The Effect of Generic Competition on the Price of Brand-name Drugs’, Health Policy
Lofton, K. E.: 2005, ‘The Difficult Realties of Healthcare in Our Country’, Frontiers of Health Services Management
MacInnis, D. J. and B. Jaworski: 1989, ‘Information Processing from Advertisements: Toward an Integrative Framework’, Journal of Marketing
MacInnis, D.J. and C. Moorman: 1991, ‘Enhancing Consumers’ Motivation, Ability and Opportunity to Process Brand Information from Ads’, Journal of Marketing
55 (October), 32-53.CrossRef
Marshall, K. P., M. Skiba, and D. P. Paul: 2009, ‘The Need for a Social Marketing Perspective of Consumer-Driven Health Care,’ International Journal of Pharmaceutical and Healthcare Marketing,
Menzel, P. T.: 1990, Strong Medicine: The Ethical Rationing of Health Care. (Oxford University Press, Oxford).
Miller, T.: 2006: ‘Getting on the Soapbox: Views of an Innovator in Consumer-Directed Care’, Health Affairs
, w549–w551 (published online 24 October 2006; 10.1377/hkhaff.25.w549
Mitroff, I. I.: 1983, Stakeholders of the Organizational Mind (Jossey-Bass Publishers, London).
Moynihan, R. and A. Cassels: 2005, Selling Sickness: How the World’s Biggest Pharmaceutical Companies Are Turning Us All into Patients (Nation Books, New York).
Newhouse, J. P. and the Insurance Experiment Group. 1994: Free for AIP Lessons from the RAND Health insurance Experiment (Harvard University Press, Cambridge, Mass.).
Penz, G. P.: 1986, Consumer Sovereignty and Human Interests, (Cambridge University Press, Cambridge).
Plender, J.: 1997, A Stake in the Future: The Stakeholding Solution (Nicholas Brealey, London).
Porter, M.E. and E.O. Teisberg: 2004, ‘Redefining Competition in Health Care,’ Harvard Business Review, 82(6), 65-76.
Poskocil, A.: 2009, ‘Bottom Line: For-Profit Care Drives up Costs’, The Roanoke Times, October 17, p. 15.
Rahtz, D. R. and L. R. Szykman.: 2008, ‘Can Health Care Organizations Better Contribute to Quality of Life by Focusing on Preventive Health Knowledge’? Journal of Marcomarketing
Rakowski, E.: 1991, Equal Justice (Oxford University Press, Oxford).
Ramaswami, S., T. Strader and K. Brett: 1998, ‘Electronic Channel Customers for Financial Products: Test of Ability-Motivation-Opportunity Model’, Proceedings of the Association of Information Systems, Americas Conference, August, pp. 300–328.
Rawls J.: 1971, A Theory of Justice (Harvard University Press, Cambridge, MA).
Ray, M. L.: 1985, ‘An Even More Powerful Consumer?’, in R. D. Buzzell (eds.), Marketing in an Electronic Age, (Harvard Business School Press, Boston).
Reidenbach, R. E. and B. Sadifer-Smallwood:1990, ‘Exploring Perceptions of Hospital Operations by a Modified SERVQUAL Approach’, Journal of Health Care Marketing, 10 (1), 47-66.
Rizzo, J. A.: 1999, ‘Advertising and Competition in the Ethical Pharmaceutical Industry: The Case of Antihypertensive Drugs’, Journal of Law and Economics
Rodge, L.: 1971, Marketing in a Competitive Economy (Cassell & Company Ltd, London).
Roijakkers, N. and J. Hagedoorn: 2006, ‘Inter-Firm R&D Partnering in Pharmaceutical Biotechnology since 1975: Trends, Patterns, and Networks’, Research Policy
Ruger, J. P.: 2008, ‘Ethics in American Health 1: Ethical Approaches to Health Policy’, American Journal of Public Health
Sandel, M. J.: 1984, Liberalism and Its Critics, (New York University Press, New York).
Schultz, R. S.: 2002. ‘Consumer-Managed Health Care,’ Journal of Financial Service Professionals
56 (6), 23-26.
Schumpeter, J. A.: 1942, Capitalism, Socialism, and Democracy (Unwin, London).
Schwartz, D. A.: 1972, ‘Sometimes It Doesn’t Pay to Follow the Leader’, Sales Management
109 (October), 42-44.
Sirgy, M. J. and C. Su: 2000, ‘The Ethics of Consumer Sovereignty in an Age of High Tech’, Journal of Business Ethics
Slate, S. F. and J. C. Narver: 1994, ‘Does Competitive Environment Moderate the Market Orientation-Performance Relationship?’ Journal of Marketing
Smedley, B. D., A.Y. Stith, and A. R. Nelson, eds. 2003: Unequal Treatment: Confronting Racial and Ethnic Disparities in Health (National Academies Press, Washington).
Smith, N. G.: 1995, ‘Marketing Strategies for the Ethics Era’, Sloan Management Review
60 (Summer), 85-97.
Song, X. M. and M. E. Parry: 1997, ‘Teamwork Barriers in Japanese High-Technology Firms: The Sociocultural Differences between R&D and Marketing Managers’, Journal of Product Innovation Management
Strader, T. and A. Hendrickson: 1999, ‘Consumer Opportunity, Ability and Motivation as a Framework for Market Research’, Electronic Markets 9(1/2), 5-8.
Taggart, J.:1993. The World Pharmaceutical Industry (Routledge, London).
Takeuchi, H. and I. Nonaka: 1986, ‘The New Product Development Game’, Harvard Business Review
66 (1), 137-146.
The Guardian: 2000, ‘A Bitter Pill for the World’s Poor’, The Guardian, January 5.
Tu, H. and J. L. Hargraves: 2003, Seeking Health Care Information: Most Consumers Still on the Sidelines, Issue Brief no. 61 (Center for Studying Health System Change, Washington).
U.S. Department of Health and Human Services: 2006, ‘National Healthcare Disparities Report, 2006’, December 2006, http://www.ahrq.gov/qual/nhdr06/nhdr06.htm
. Accessed 13 April 2007.
Walzer, M.: 1990, ‘The Communitarian Critique of Liberalism’, Political Theory
Wheeler, D. and M. Sillanpaa: 1997, The Stakeholder Corporation: A Blueprint for Maximizing Stakeholder Value (Pitman Publishing, London)
Wheelwright, C.: 1993, Managing New Product and Process Development, (The Free Press, New York).
Wonglimpiyarat, J.: 2008. ‘Technological Change in the Pharmaceutical Industry: Policies for Technology Transfer and Management for the Developing Countries’, International Journal of Technology, Policy and Management
Yeoh, P-L. and K. Roth: 1999. ‘An Empirical Analysis of Sustained Advantages in the U.S. Pharmaceutical Industry: Impact of Firm Resources and Capabilities’, Strategic Management Journal
Zeithaml, V.A.:1988, ‘Consumer Perceptions of Price, Quality, and Value: A Means-End Model and Synthesis of Evidence,’ Journal of Marketing
, 52(3) July, 2-22.CrossRef